|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
decreases activity multiple interactions |
EXP |
telmisartan results in decreased activity of ABCB11 protein telmisartan inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] |
CTD |
PMID:20829430 PMID:23956101 PMID:24014644 |
|
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
ABCG1 |
ATP binding cassette subfamily G member 1 |
multiple interactions increases expression |
EXP |
PPARG mutant form inhibits the reaction [telmisartan results in increased expression of ABCG1 mRNA] |
CTD |
PMID:22124178 |
|
NCBI chr21:42,199,689...42,297,244
Ensembl chr21:42,199,689...42,297,244
|
|
G |
ACE |
angiotensin I converting enzyme |
decreases expression multiple interactions |
ISO |
Telmisartan results in decreased expression of ACE mRNA; Telmisartan results in decreased expression of ACE protein Telmisartan inhibits the reaction [Pregabalin results in increased expression of ACE protein] |
CTD |
PMID:19171132 PMID:25973029 PMID:29909460 PMID:31629013 |
|
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
|
|
G |
ACE2 |
angiotensin converting enzyme 2 |
multiple interactions decreases expression increases expression |
ISO |
telmisartan inhibits the reaction [Streptozocin results in decreased expression of ACE2 protein] telmisartan decreases expression of mRNA in mandible of rats with periodontal disease Telmisartan inhibits the reaction [Pregabalin results in decreased expression of ACE2 protein] Telmisartan results in decreased expression of ACE2 mRNA; Telmisartan results in decreased expression of ACE2 protein Telmisartan results in increased expression of ACE2 mRNA; Telmisartan results in increased expression of ACE2 protein |
CTD RGD |
PMID:21381899 PMID:25973029 PMID:28656296 PMID:29909460 PMID:31629013 PMID:33364953 More...
|
RGD:329956421 |
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
|
|
G |
ACHE |
acetylcholinesterase (Yt blood group) |
multiple interactions |
ISO |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [telmisartan inhibits the reaction [Streptozocin results in increased activity of ACHE protein]]; telmisartan inhibits the reaction [Streptozocin results in increased activity of ACHE protein] |
CTD |
PMID:23060470 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
ACP5 |
acid phosphatase 5, tartrate resistant |
decreases activity |
ISO |
telmisartan decreases enzyme activity of Trap, Acp5 in serum of rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr19:11,574,660...11,578,975
Ensembl chr19:11,574,653...11,579,993
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
increases expression |
ISO EXP |
telmisartan results in increased expression of ADIPOQ mRNA telmisartan results in increased expression of ADIPOQ protein |
CTD |
PMID:19730415 PMID:20555330 |
|
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
|
|
G |
AGT |
angiotensinogen |
multiple interactions decreases expression |
ISO |
telmisartan inhibits the reaction [[AGT protein modified form co-treated with AGTR1A co-treated with AGTR1B] results in increased expression of SERPINE1 mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of IL6 protein] telmisartan results in decreased expression of AGT mRNA; telmisartan results in decreased expression of AGT protein Telmisartan inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA]; Telmisartan inhibits the reaction [AGT protein results in decreased expression of SYP protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of AGTR1A mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1H mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of CRH protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of FOS protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of IL1B protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of IL6 protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of SERPINE1 mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of TGFB1 protein]; Telmisartan inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]; Telmisartan inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]; Telmisartan inhibits the reaction [AGT protein results in increased ubiquitination of SYP protein]; Telmisartan inhibits the reaction [arsenite results in increased expression of AGT protein]; Telmisartan inhibits the reaction [Diatrizoate results in increased expression of AGT protein]; Telmisartan inhibits the reaction [Iohexol results in increased expression of AGT protein]; Telmisartan inhibits the reaction [Pregabalin results in decreased expression of AGT protein] |
CTD |
PMID:9533614 PMID:17620961 PMID:18487452 PMID:19171132 PMID:19289654 PMID:19292980 PMID:19452295 PMID:19706694 PMID:31629013 PMID:33872574 PMID:34339004 More...
|
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
AGTR1 |
angiotensin II receptor type 1 |
affects binding decreases expression multiple interactions increases expression |
ISO EXP |
telmisartan binds to AGTR1 protein telmisartan decreases expression of mRNA in mandible of rats with periodontal disease telmisartan inhibits the reaction [[AGT protein modified form co-treated with AGTR1A co-treated with AGTR1B] results in increased expression of SERPINE1 mRNA]; telmisartan inhibits the reaction [Streptozocin results in increased expression of AGTR1A protein] telmisartan results in decreased expression of AGTR1A mRNA telmisartan binds to and results in decreased activity of AGTR1 protein Telmisartan binds to and results in decreased activity of AGTR1 protein; Telmisartan inhibits the reaction [AGT protein results in increased expression of AGTR1A mRNA]; Telmisartan inhibits the reaction [Daunorubicin results in increased expression of AGTR1A protein]; Telmisartan inhibits the reaction [Pregabalin results in increased expression of AGTR1 protein] telmisartan results in increased expression of AGTR1 mRNA |
CTD RGD |
PMID:8220885 PMID:9533614 PMID:9728324 PMID:17620961 PMID:19171132 PMID:19706694 PMID:20888384 PMID:21381899 PMID:21557540 PMID:31629013 PMID:33364953 More...
|
RGD:329956421 |
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
|
|
G |
AGTR2 |
angiotensin II receptor type 2 |
increases expression |
ISO |
telmisartan increases expression of mRNA in mandible of rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr X:116,170,744...116,174,974
Ensembl chr X:116,170,744...116,174,974
|
|
G |
AHR |
aryl hydrocarbon receptor |
increases activity |
ISO |
Telmisartan results in increased activity of AHR protein |
CTD |
PMID:28728110 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
ALB |
albumin |
affects expression multiple interactions |
EXP ISO |
telmisartan affects the expression of ALB protein modified form Telmisartan affects the reaction [LEPR protein affects the abundance of ALB protein] |
CTD |
PMID:16671338 PMID:34464088 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
ALPL |
alkaline phosphatase, biomineralization associated |
increases activity multiple interactions |
ISO |
telmisartan increases enzyme activity of Alpl in serum of rats with periodontal disease Telmisartan inhibits the reaction [Methotrexate results in increased expression of and results in increased secretion of ALPL protein] |
CTD RGD |
PMID:27269004 PMID:33364953 |
RGD:329956421 |
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAX mRNA] |
CTD |
PMID:24831514 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA] |
CTD |
PMID:24831514 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BDNF |
brain derived neurotrophic factor |
multiple interactions |
ISO |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BDNF mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BDNF protein] |
CTD |
PMID:23747572 |
|
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
|
|
G |
CACNA1G |
calcium voltage-gated channel subunit alpha1 G |
multiple interactions decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [telmisartan results in decreased expression of CACNA1G mRNA]; SB 203580 inhibits the reaction [telmisartan results in decreased expression of CACNA1G mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA] |
CTD |
PMID:19292980 |
|
NCBI chr17:50,560,715...50,627,474
Ensembl chr17:50,560,715...50,627,474
|
|
G |
CACNA1H |
calcium voltage-gated channel subunit alpha1 H |
multiple interactions decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [telmisartan results in decreased expression of CACNA1H mRNA]; SB 203580 inhibits the reaction [telmisartan results in decreased expression of CACNA1H mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1H mRNA] |
CTD |
PMID:19292980 |
|
NCBI chr16:1,153,106...1,221,768
Ensembl chr16:1,153,103...1,224,169
|
|
G |
CASP3 |
caspase 3 |
multiple interactions decreases expression |
EXP ISO |
telmisartan inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP3 protein] Telmisartan results in decreased expression of CASP3 protein Telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 protein]; Telmisartan inhibits the reaction [Diatrizoate results in increased activity of CASP3 protein]; Telmisartan inhibits the reaction [Iohexol results in increased activity of CASP3 protein]; Telmisartan inhibits the reaction [Methotrexate results in increased expression of CASP3 protein]; Telmisartan inhibits the reaction [sodium arsenite results in increased expression of CASP3]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of and results in increased activity of CASP3 protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP3 mRNA] telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 protein]; telmisartan inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein] |
CTD |
PMID:18565324 PMID:19452295 PMID:21620867 PMID:21819444 PMID:22750630 PMID:24831514 PMID:26439596 PMID:27269004 PMID:29909460 More...
|
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [arsenite results in decreased activity of CAT protein]; Telmisartan inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Telmisartan inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein] |
CTD |
PMID:23750309 PMID:26929000 PMID:34339004 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression |
EXP ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] telmisartan results in decreased expression of CCL2 protein |
CTD |
PMID:17922026 PMID:22124178 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
decreases response to substance |
EXP |
telmisartan results in decreased susceptibility to CCL5 protein |
CTD |
PMID:18158351 |
|
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
decreases expression |
ISO |
telmisartan results in decreased expression of CCR2 mRNA |
CTD |
PMID:17922026 |
|
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
|
|
G |
CD36 |
CD36 molecule (CD36 blood group) |
increases expression multiple interactions |
EXP |
telmisartan results in increased expression of CD36 mRNA PPARG mutant form inhibits the reaction [telmisartan results in increased expression of CD36 mRNA]; T 0070907 inhibits the reaction [telmisartan results in increased expression of CD36 mRNA] |
CTD |
PMID:22124178 |
|
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
|
|
G |
CEBPB |
CCAAT enhancer binding protein beta |
multiple interactions |
ISO |
telmisartan inhibits the reaction [TNF protein promotes the reaction [CEBPB protein binds to IL6 promoter]] |
CTD |
PMID:19289654 |
|
NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668
|
|
G |
CRH |
corticotropin releasing hormone |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [AGT protein results in increased expression of CRH protein] |
CTD |
PMID:33872574 |
|
NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464
|
|
G |
CRP |
C-reactive protein |
decreases expression |
EXP |
telmisartan results in decreased expression of CRP protein |
CTD |
PMID:20555330 |
|
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
CTSK |
cathepsin K |
decreases expression |
ISO |
telmisartan decreases expression of mRNA in mandible of rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr 1:150,796,208...150,808,260
Ensembl chr 1:150,794,880...150,809,577
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
decreases expression |
ISO |
telmisartan decreases expression of protein in mandible of SHR rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL12 |
C-X-C motif chemokine ligand 12 |
multiple interactions decreases response to substance |
EXP |
PPARG protein promotes the reaction [telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein]]; telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein] telmisartan results in decreased susceptibility to CXCL12 protein |
CTD |
PMID:18158351 |
|
NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
decreases expression |
EXP |
telmisartan metabolite results in decreased expression of CXCL8 mRNA |
CTD |
PMID:26528891 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYBA |
cytochrome b-245 alpha chain |
decreases expression multiple interactions |
ISO |
telmisartan results in decreased expression of CYBA mRNA; telmisartan results in decreased expression of CYBA protein telmisartan inhibits the reaction [Daunorubicin results in increased expression of CYBA protein] |
CTD |
PMID:16141465 PMID:19171132 PMID:21054405 |
|
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
|
|
G |
CYBB |
cytochrome b-245 beta chain |
multiple interactions decreases expression |
ISO EXP |
telmisartan inhibits the reaction [Streptozocin results in increased expression of CYBB protein] Telmisartan inhibits the reaction [arsenite results in increased expression of CYBB mRNA] Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB mRNA]; Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB protein] telmisartan results in decreased expression of CYBB mRNA |
CTD |
PMID:19171132 PMID:21381899 PMID:34339004 PMID:34464088 |
|
NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461
|
|
G |
CYCS |
cytochrome c, somatic |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CYCS mRNA] |
CTD |
PMID:24831514 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYP2J2 |
cytochrome P450 family 2 subfamily J member 2 |
decreases activity |
EXP |
Telmisartan results in decreased activity of CYP2J2 protein |
CTD |
PMID:30965050 |
|
NCBI chr 1:59,893,308...59,969,212
Ensembl chr 1:59,893,308...59,926,773
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
decreases expression |
ISO |
telmisartan results in decreased expression of DDIT3 protein |
CTD |
PMID:19102871 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
EDN1 |
endothelin 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Daunorubicin results in increased expression of EDN1 protein] |
CTD |
PMID:20888384 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
EDNRA |
endothelin receptor type A |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Daunorubicin results in increased expression of EDNRA protein] |
CTD |
PMID:20888384 |
|
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
|
|
G |
EDNRB |
endothelin receptor type B |
multiple interactions |
ISO |
telmisartan promotes the reaction [Daunorubicin results in increased expression of EDNRB protein] |
CTD |
PMID:20888384 |
|
NCBI chr13:77,895,481...77,975,527
Ensembl chr13:77,895,481...77,975,529
|
|
G |
FASLG |
Fas ligand |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASL protein] telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASLG protein] |
CTD |
PMID:21620867 PMID:21819444 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FN1 |
fibronectin 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 protein] |
CTD |
PMID:19706694 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [AGT protein results in increased expression of FOS protein] |
CTD |
PMID:33872574 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
GDNF |
glial cell derived neurotrophic factor |
multiple interactions |
ISO |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GDNF mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GDNF protein] |
CTD |
PMID:23747572 |
|
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
|
|
G |
GFAP |
glial fibrillary acidic protein |
multiple interactions decreases expression |
ISO |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of GFAP protein] Telmisartan results in decreased expression of GFAP protein |
CTD |
PMID:23747572 PMID:29909460 |
|
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
|
|
G |
GGT1 |
gamma-glutamyltransferase 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of GGT1 protein] |
CTD |
PMID:23750309 |
|
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
|
|
G |
GJA1 |
gap junction protein alpha 1 |
multiple interactions |
EXP |
Telmisartan inhibits the reaction [Dibutyl Phthalate results in increased expression of GJA1 protein] |
CTD |
PMID:37356649 |
|
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
|
|
G |
GOT1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [Methotrexate results in increased expression of and results in increased secretion of GOT1 protein] |
CTD |
PMID:27269004 |
|
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein]; Telmisartan inhibits the reaction [Methotrexate results in increased expression of and results in increased secretion of GPT protein] |
CTD |
PMID:26929000 PMID:27269004 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions decreases activity |
ISO |
Telmisartan inhibits the reaction [arsenite results in decreased activity of GSR protein] Telmisartan results in decreased activity of GSR protein |
CTD |
PMID:34339004 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
HGF |
hepatocyte growth factor |
increases expression |
ISO |
telmisartan results in increased expression of HGF mRNA |
CTD |
PMID:21479465 |
|
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression |
ISO |
telmisartan results in decreased expression of HSPA5 protein |
CTD |
PMID:19102871 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
IBSP |
integrin binding sialoprotein |
increases expression |
ISO |
telmisartan increases expression of mRNA in mandible of WKY rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr 4:87,799,554...87,812,435
Ensembl chr 4:87,799,554...87,812,435
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
multiple interactions |
EXP ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein] telmisartan inhibits the reaction [Daunorubicin results in increased expression of ICAM1 protein] telmisartan inhibits the reaction [Streptozocin results in increased expression of ICAM1 mRNA] |
CTD |
PMID:17724226 PMID:20888384 PMID:22124178 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
ICAM3 |
intercellular adhesion molecule 3 |
multiple interactions |
EXP |
PPARG protein promotes the reaction [telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein]]; telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein] |
CTD |
PMID:18158351 |
|
NCBI chr19:10,333,776...10,339,624
Ensembl chr19:10,333,776...10,339,661
|
|
G |
IL10 |
interleukin 10 |
multiple interactions decreases expression increases expression |
ISO |
telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein] telmisartan decreases expression of protein in mandible of WKY rats with periodontal disease Telmisartan results in increased expression of IL10 protein |
CTD RGD |
PMID:24831514 PMID:29909460 PMID:33364953 |
RGD:329956421 |
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions decreases expression |
EXP ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] telmisartan decreases expression of protein in mandible of SHR rats with periodontal disease Telmisartan inhibits the reaction [AGT protein results in increased expression of IL1B protein]; Telmisartan inhibits the reaction [arsenite results in increased expression of IL1B protein] |
CTD RGD |
PMID:22124178 PMID:33872574 PMID:34339004 PMID:33364953 |
RGD:329956421 |
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions decreases expression |
EXP ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] Telmisartan results in decreased expression of IL6 protein telmisartan results in decreased expression of IL6 mRNA 2-chloro-5-nitrobenzanilide inhibits the reaction [Telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; Telmisartan inhibits the reaction [AGT protein results in increased expression of IL6 protein]; Telmisartan inhibits the reaction [arsenite results in increased expression of IL6 protein]; Telmisartan inhibits the reaction [TNF protein promotes the reaction [CEBPB protein binds to IL6 promoter]]; Telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; Telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 protein] telmisartan inhibits the reaction [AGT protein results in increased expression of IL6 protein]; telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 protein] |
CTD |
PMID:19289654 PMID:21479465 PMID:22124178 PMID:29909460 PMID:34339004 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INS |
insulin |
decreases expression |
EXP |
telmisartan results in decreased expression of INS protein |
CTD |
PMID:15892894 |
|
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
increases expression |
ISO |
Telmisartan results in increased expression of INS1 protein |
CTD |
PMID:19171132 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
IRAK1 |
interleukin 1 receptor associated kinase 1 |
multiple interactions |
EXP |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of IRAK1 mRNA |
CTD |
PMID:20524934 |
|
NCBI chr X:154,010,507...154,019,902
Ensembl chr X:154,010,506...154,019,902
|
|
G |
KCNN4 |
potassium calcium-activated channel subfamily N member 4 |
decreases expression |
EXP |
telmisartan decreases expression of KCNN4 mRNA and protein in CD4-positive alpha-beta T cell |
RGD |
PMID:26502942 |
RGD:329955577 |
NCBI chr19:43,766,533...43,780,973
Ensembl chr19:43,766,533...43,780,976
|
|
G |
LEPR |
leptin receptor |
multiple interactions |
ISO |
Telmisartan affects the reaction [LEPR protein affects the abundance of ALB protein]; Telmisartan affects the reaction [LEPR protein affects the expression of OCLN mRNA] |
CTD |
PMID:34464088 |
|
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
|
|
G |
LIPE |
lipase E, hormone sensitive type |
multiple interactions increases expression |
ISO |
PPARD promotes the reaction [telmisartan results in increased expression of LIPE protein] |
CTD |
PMID:20176998 |
|
NCBI chr19:42,401,514...42,427,388
Ensembl chr19:42,401,514...42,427,388
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] Telmisartan inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:22124178 PMID:33872574 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
multiple interactions decreases phosphorylation |
EXP ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] telmisartan results in decreased phosphorylation of MAPK14 protein |
CTD |
PMID:19292980 PMID:22124178 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] Telmisartan inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:22124178 PMID:33872574 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPKAPK2 |
MAPK activated protein kinase 2 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Streptozocin results in increased expression of MAPKAPK2 protein modified form] |
CTD |
PMID:21381899 |
|
NCBI chr 1:206,684,905...206,734,281
Ensembl chr 1:206,684,905...206,734,281
|
|
G |
MAS1 |
MAS1 proto-oncogene, G protein-coupled receptor |
multiple interactions increases expression |
ISO |
telmisartan inhibits the reaction [Streptozocin results in decreased expression of MAS1 protein] Telmisartan inhibits the reaction [Pregabalin results in decreased expression of MAS1 protein] Telmisartan results in increased expression of MAS1 protein |
CTD |
PMID:21381899 PMID:28656296 PMID:31629013 |
|
NCBI chr 6:159,888,787...159,917,447
Ensembl chr 6:159,890,988...159,917,447
|
|
G |
MIR146A |
microRNA 146a |
multiple interactions |
EXP ISO |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of MIR146A telmisartan inhibits the reaction [ischemia-reperfusion injury increases expression of Mir146a miRNA in kidney] |
CTD RGD |
PMID:20524934 PMID:27760486 |
RGD:155882556 |
NCBI chr 5:160,485,352...160,485,450
Ensembl chr 5:160,485,352...160,485,450
|
|
G |
MIR146B |
microRNA 146b |
multiple interactions |
EXP |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of MIR146B |
CTD |
PMID:20524934 |
|
NCBI chr10:102,436,512...102,436,584
Ensembl chr10:102,436,512...102,436,584
|
|
G |
MIR320A |
microRNA 320a |
multiple interactions |
ISO |
telmisartan inhibits the reaction [ischemia-reperfusion injury increases expression of Mir320a miRNA in kidney] |
RGD |
PMID:27760486 |
RGD:155882556 |
NCBI chr 8:22,244,966...22,245,037
Ensembl chr 8:22,244,962...22,245,043
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
decreases expression decreases expression |
ISO |
telmisartan results in decreased expression of MMP2 protein telmisartan decreases expression of mRNA in mandible of WKY rats with periodontal disease |
CTD RGD |
PMID:21054405 PMID:33364953 |
RGD:329956421 |
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
decreases expression |
ISO |
telmisartan decreases expression of mRNA in mandible of SHR rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MPO |
myeloperoxidase |
multiple interactions |
ISO |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [telmisartan inhibits the reaction [Streptozocin results in increased activity of MPO protein]]; telmisartan inhibits the reaction [Streptozocin results in increased activity of MPO protein] telmisartan inhibits the reaction [Carbon Tetrachloride results in increased activity of MPO protein]; telmisartan inhibits the reaction [sodium arsenite results in increased activity of MPO protein]; telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein] |
CTD |
PMID:23060470 PMID:24831514 PMID:26439596 PMID:26929000 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
MYLK |
myosin light chain kinase |
multiple interactions |
EXP |
MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]]; Telmisartan inhibits the reaction [Glucose results in increased expression of MYLK mRNA]; Telmisartan inhibits the reaction [Glucose results in increased expression of MYLK protein] |
CTD |
PMID:34464088 |
|
NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332
|
|
G |
NCF1 |
neutrophil cytosolic factor 1 |
multiple interactions decreases expression |
ISO |
telmisartan inhibits the reaction [Streptozocin results in increased expression of NCF1 protein] telmisartan inhibits the reaction [Daunorubicin results in increased expression of NCF1 protein] telmisartan results in decreased expression of NCF1 mRNA; telmisartan results in decreased expression of NCF1 protein |
CTD |
PMID:16141465 PMID:19171132 PMID:21054405 PMID:21381899 |
|
NCBI chr 7:74,774,011...74,789,315
Ensembl chr 7:74,774,011...74,789,315
|
|
G |
NCF2 |
neutrophil cytosolic factor 2 |
multiple interactions decreases expression |
ISO |
telmisartan inhibits the reaction [Streptozocin results in increased expression of NCF2 protein] telmisartan inhibits the reaction [Daunorubicin results in increased expression of NCF2 protein] telmisartan results in decreased expression of NCF2 mRNA; telmisartan results in decreased expression of NCF2 protein |
CTD |
PMID:16141465 PMID:21054405 PMID:21381899 |
|
NCBI chr 1:183,555,562...183,601,849
Ensembl chr 1:183,554,461...183,590,905
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of NFKB1 protein] |
CTD |
PMID:21620867 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
EXP |
PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA] |
CTD |
PMID:22124178 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of NOS2 protein]; telmisartan inhibits the reaction [sodium arsenite results in increased expression of NOS2 protein] Telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of NOS2 protein]; Telmisartan inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein]; Telmisartan inhibits the reaction [Methotrexate results in increased expression of NOS2 protein]; Telmisartan inhibits the reaction [sodium arsenite results in increased expression of NOS2]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA] |
CTD |
PMID:21620867 PMID:21819444 PMID:22750630 PMID:24831514 PMID:26439596 PMID:26929000 PMID:27269004 More...
|
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions increases phosphorylation increases expression |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan results in increased expression of NOS3 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan results in increased phosphorylation of NOS3 protein] |
CTD |
PMID:21156825 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NOX4 |
NADPH oxidase 4 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Daunorubicin results in increased expression of NOX4 protein] |
CTD |
PMID:21054405 |
|
NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187
|
|
G |
NPHS1 |
NPHS1 adhesion molecule, nephrin |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [Daunorubicin results in decreased expression of NPHS1 protein] |
CTD |
PMID:20888384 |
|
NCBI chr19:35,862,915...35,869,357
Ensembl chr19:35,825,964...35,869,287
|
|
G |
NPPB |
natriuretic peptide B |
affects expression multiple interactions decreases expression |
EXP ISO |
telmisartan affects the expression of NPPB protein Telmisartan inhibits the reaction [Pregabalin results in increased expression of NPPB protein] telmisartan results in decreased expression of NPPB protein |
CTD |
PMID:16671338 PMID:18712048 PMID:31629013 |
|
NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
|
|
G |
OCLN |
occludin |
multiple interactions |
EXP ISO |
MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]]; Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]; Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN protein] Telmisartan affects the reaction [LEPR protein affects the expression of OCLN mRNA] |
CTD |
PMID:34464088 |
|
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
|
|
G |
OLR1 |
oxidized low density lipoprotein receptor 1 |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of OLR1 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of OLR1 protein] |
CTD |
PMID:22124178 |
|
NCBI chr12:10,158,301...10,176,266
Ensembl chr12:10,158,301...10,172,138
|
|
G |
PLAU |
plasminogen activator, urokinase |
multiple interactions |
ISO |
telmisartan inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
|
|
G |
PPARD |
peroxisome proliferator activated receptor delta |
increases expression multiple interactions |
ISO |
telmisartan results in increased expression of PPARD protein PPARD promotes the reaction [telmisartan results in increased expression of LIPE protein]; PPARD promotes the reaction [telmisartan results in increased expression of UCP1 protein]; PPARD promotes the reaction [telmisartan results in increased expression of UCP2 protein]; PPARD promotes the reaction [telmisartan results in increased expression of UCP3 protein] |
CTD |
PMID:20176998 |
|
NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions increases expression increases activity |
EXP ISO |
PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]]; PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; PPARG mutant form inhibits the reaction [telmisartan results in increased expression of ABCG1 mRNA]; PPARG mutant form inhibits the reaction [telmisartan results in increased expression of CD36 mRNA]; PPARG protein promotes the reaction [telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein]] telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]; telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein] telmisartan results in increased expression of PPARG protein telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] Telmisartan results in increased activity of PPARG protein |
CTD |
PMID:18158351 PMID:20176998 PMID:20888384 PMID:21381899 PMID:22124178 PMID:24831514 PMID:28728110 More...
|
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PPARGC1A |
PPARG coactivator 1 alpha |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARGC1A protein] |
CTD |
PMID:21381899 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
G |
PRKAA2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
multiple interactions |
EXP |
Telmisartan inhibits the reaction [Dibutyl Phthalate results in increased expression of PRKAA2 protein] |
CTD |
PMID:37356649 |
|
NCBI chr 1:56,645,314...56,715,335
Ensembl chr 1:56,645,314...56,715,335
|
|
G |
PRKACA |
protein kinase cAMP-activated catalytic subunit alpha |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [Pregabalin results in decreased expression of PRKACA protein] |
CTD |
PMID:31629013 |
|
NCBI chr19:14,091,688...14,117,762
Ensembl chr19:14,091,688...14,118,084
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases activity |
EXP ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] Telmisartan results in increased activity of PTGS2 protein telmisartan inhibits the reaction [sodium arsenite results in increased expression of PTGS2 protein] [Telmisartan co-treated with Aspirin] inhibits the reaction [Streptozocin results in increased expression of PTGS2 protein]; Telmisartan inhibits the reaction [arsenite results in increased activity of PTGS2 protein]; Telmisartan inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein]; Telmisartan inhibits the reaction [Daunorubicin results in increased expression of PTGS2 protein]; Telmisartan inhibits the reaction [Methotrexate results in increased expression of PTGS2 protein]; Telmisartan inhibits the reaction [sodium arsenite results in increased expression of PTGS2]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] |
CTD |
PMID:20223228 PMID:20888384 PMID:22124178 PMID:22750630 PMID:24831514 PMID:26439596 PMID:26929000 PMID:27269004 PMID:34339004 More...
|
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTH1R |
parathyroid hormone 1 receptor |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of PTH1R protein] |
CTD |
PMID:23750309 |
|
NCBI chr 3:46,877,721...46,903,799
Ensembl chr 3:46,877,721...46,903,799
|
|
G |
PTHLH |
parathyroid hormone like hormone |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of PTHLH protein] |
CTD |
PMID:23750309 |
|
NCBI chr12:27,958,084...27,972,733
Ensembl chr12:27,958,084...27,972,733
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO EXP |
[telmisartan co-treated with Aspirin] inhibits the reaction [Streptozocin results in increased expression of RELA protein]; telmisartan inhibits the reaction [Carbon Tetrachloride results in increased expression of RELA protein]; telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RELA mRNA]; telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RELA protein] telmisartan inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein] |
CTD |
PMID:20223228 PMID:22124178 PMID:24831514 PMID:26929000 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
REN |
renin |
increases expression |
ISO |
telmisartan results in increased expression of REN mRNA; telmisartan results in increased expression of REN protein |
CTD |
PMID:9533614 |
|
NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324
|
|
G |
RUNX2 |
RUNX family transcription factor 2 |
increases expression |
ISO |
telmisartan increases expression of mRNA in mandible of rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
|
|
G |
SCN5A |
sodium voltage-gated channel alpha subunit 5 |
increases activity |
EXP |
telmisartan results in increased activity of SCN5A protein |
CTD |
PMID:29306026 |
|
NCBI chr 3:38,548,062...38,649,687
Ensembl chr 3:38,548,057...38,649,743
|
|
G |
SEMA3B |
semaphorin 3B |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Calcitriol results in increased expression of SEMA3B protein]; telmisartan inhibits the reaction [Progesterone results in increased expression of SEMA3B protein] |
CTD |
PMID:21933904 |
|
NCBI chr 3:50,267,652...50,277,546
Ensembl chr 3:50,267,558...50,277,546
|
|
G |
SEMA3F |
semaphorin 3F |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Calcitriol results in increased expression of SEMA3F protein]; telmisartan inhibits the reaction [Progesterone results in increased expression of SEMA3F protein] |
CTD |
PMID:21933904 |
|
NCBI chr 3:50,155,058...50,189,075
Ensembl chr 3:50,155,045...50,189,075
|
|
G |
SERPINE1 |
serpin family E member 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [[AGT protein modified form co-treated with AGTR1A co-treated with AGTR1B] results in increased expression of SERPINE1 mRNA]; telmisartan inhibits the reaction [Hydrogen Peroxide results in increased expression of SERPINE1 mRNA] telmisartan inhibits the reaction [AGT protein results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:17620961 PMID:19706694 |
|
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SLC18A2 |
solute carrier family 18 member A2 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC18A2 protein] |
CTD |
PMID:23747572 |
|
NCBI chr10:117,241,114...117,279,430
Ensembl chr10:117,241,093...117,279,430
|
|
G |
SLC22A2 |
solute carrier family 22 member 2 |
multiple interactions |
EXP |
telmisartan inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
|
|
G |
SLC6A3 |
solute carrier family 6 member 3 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC6A3 mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC6A3 protein] |
CTD |
PMID:23747572 |
|
NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,440
|
|
G |
SNCA |
synuclein alpha |
multiple interactions |
ISO |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SNCA mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SNCA protein] |
CTD |
PMID:23747572 |
|
NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [Methotrexate results in decreased expression of and results in decreased activity of SOD1 protein] |
CTD |
PMID:27269004 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SPP1 |
secreted phosphoprotein 1 |
increases expression |
ISO |
telmisartan increases expression of mRNA in mandible of WKY rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
|
|
G |
SYP |
synaptophysin |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Streptozocin results in decreased expression of SYP protein] telmisartan inhibits the reaction [AGT protein results in decreased expression of SYP protein]; telmisartan inhibits the reaction [AGT protein results in increased ubiquitination of SYP protein] |
CTD |
PMID:18487452 |
|
NCBI chr X:49,187,815...49,200,193
Ensembl chr X:49,187,815...49,200,218
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions decreases expression |
ISO |
telmisartan inhibits the reaction [Streptozocin results in increased expression of TGFB1 protein] telmisartan results in decreased expression of TGFB1 mRNA telmisartan inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of TGFB1 protein]; telmisartan inhibits the reaction [Daunorubicin results in increased expression of TGFB1 protein] |
CTD |
PMID:19171132 PMID:19706694 PMID:20888384 PMID:21381899 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TH |
tyrosine hydroxylase |
multiple interactions |
ISO |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH protein] |
CTD |
PMID:23747572 |
|
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
|
|
G |
TJP1 |
tight junction protein 1 |
multiple interactions decreases expression affects localization |
EXP |
2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan affects the localization of TJP1 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan results in decreased expression of TJP1 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan results in decreased expression of TJP1 protein]; wortmannin inhibits the reaction [telmisartan affects the localization of TJP1 protein]; wortmannin inhibits the reaction [telmisartan results in decreased expression of TJP1 mRNA]; wortmannin inhibits the reaction [telmisartan results in decreased expression of TJP1 protein] Telmisartan results in decreased expression of TJP1 mRNA; Telmisartan results in decreased expression of TJP1 protein |
CTD |
PMID:19252288 |
|
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
|
|
G |
TLR4 |
toll like receptor 4 |
multiple interactions |
EXP |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of TLR4 mRNA; [Atorvastatin co-treated with Telmisartan] results in decreased expression of TLR4 protein |
CTD |
PMID:20524934 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions decreases expression |
EXP ISO |
PPARG mutant form inhibits the reaction [Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; T 0070907 inhibits the reaction [Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; T 0070907 inhibits the reaction [Telmisartan inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Telmisartan inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] telmisartan decreases expression of protein in mandible of SHR rats with periodontal disease Telmisartan results in decreased expression of TNF protein telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of TNF protein]; telmisartan inhibits the reaction [sodium arsenite results in increased expression of TNF protein]; telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 protein] 2-chloro-5-nitrobenzanilide inhibits the reaction [Telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; [Telmisartan co-treated with Aspirin] inhibits the reaction [Streptozocin results in increased expression of TNF protein]; Telmisartan inhibits the reaction [arsenite results in increased expression of TNF protein]; Telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of TNF]; Telmisartan inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]; Telmisartan inhibits the reaction [sodium arsenite results in increased expression of TNF]; Telmisartan inhibits the reaction [TNF protein promotes the reaction [CEBPB protein binds to IL6 promoter]]; Telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; Telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein] |
CTD RGD |
PMID:19289654 PMID:20223228 PMID:21620867 PMID:21819444 PMID:22124178 PMID:22750630 PMID:24831514 PMID:26439596 PMID:26929000 PMID:29909460 PMID:34339004 PMID:33364953 More...
|
RGD:329956421 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF11B |
TNF receptor superfamily member 11b |
increases expression |
ISO |
telmisartan increases expression of mRNA in mandible of WKY rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
|
|
G |
TNFSF11 |
TNF superfamily member 11 |
decreases expression |
ISO |
telmisartan decreases expression of mRNA in mandible of SHR rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
|
|
G |
TRAF6 |
TNF receptor associated factor 6 |
multiple interactions |
EXP |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of TRAF6 mRNA |
CTD |
PMID:20524934 |
|
NCBI chr11:36,483,769...36,510,272
Ensembl chr11:36,483,769...36,510,272
|
|
G |
UCP1 |
uncoupling protein 1 |
multiple interactions increases expression |
ISO |
PPARD promotes the reaction [telmisartan results in increased expression of UCP1 protein] |
CTD |
PMID:20176998 |
|
NCBI chr 4:140,559,431...140,568,961
Ensembl chr 4:140,559,431...140,568,961
|
|
G |
UCP2 |
uncoupling protein 2 |
multiple interactions increases expression |
ISO |
PPARD promotes the reaction [telmisartan results in increased expression of UCP2 protein] |
CTD |
PMID:20176998 |
|
NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,672...73,982,843
|
|
G |
UCP3 |
uncoupling protein 3 |
multiple interactions increases expression |
ISO |
PPARD promotes the reaction [telmisartan results in increased expression of UCP3 protein] |
CTD |
PMID:20176998 |
|
NCBI chr11:74,000,277...74,009,085
Ensembl chr11:74,000,277...74,009,085
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Daunorubicin results in increased expression of VCAM1 protein] |
CTD |
PMID:20888384 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions decreases expression |
ISO |
telmisartan inhibits the reaction [Streptozocin results in increased expression of VEGFA mRNA] telmisartan inhibits the reaction [sodium arsenite results in increased expression of VEGFA] telmisartan results in decreased expression of VEGFA mRNA |
CTD |
PMID:17724226 PMID:19171132 PMID:26439596 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
VTN |
vitronectin |
decreases expression |
ISO |
telmisartan decreases expression of mRNA in mandible of SHR rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr17:28,367,284...28,370,307
Ensembl chr17:28,367,284...28,373,091
|
|